Form 8-K - Current report:
SEC Accession No. 0000950123-05-013036
Filing Date
2005-11-03
Accepted
2005-11-03 15:14:38
Documents
4
Period of Report
2005-10-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y14178e8vk.htm 8-K 15527
2 EX-99.1: PRESS RELEASE y14178exv99w1.htm EX-99.1 76896
3 EX-99.2: TEXTUAL REPRESENTATION OF PORTIONS OF WEBCAST CONFERENCE CALL y14178exv99w2.htm EX-99.2 53643
4 GRAPHIC y14178y1417800.gif GRAPHIC 3308
  Complete submission text file 0000950123-05-013036.txt   152466
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 051176670
SIC: 2835 In Vitro & In Vivo Diagnostic Substances